For: | Sargin H, Sargin M, Gozu H, Orcun A, Baloglu G, Ozisik M, Seker M, Uygur-Bayramicli O. Is adiponectin level a predictor of nonalcoholic fatty liver disease in nondiabetic male patients? World J Gastroenterol 2005; 11(37): 5874-5877 [PMID: 16270401 DOI: 10.3748/wjg.v11.i37.5874] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i37/5874.htm |
Number | Citing Articles |
1 |
Vincent Wai‐Sun Wong, Grace Lai‐Hung Wong, Steven Woon‐Choi Tsang, Alex Yui Hui, Anthony Wing‐Hong Chan, Paul Cheung‐Lung Choi, Wing‐Yee So, Ada Mei‐Ling Tse, Francis Ka‐Leung Chan, Joseph Jao‐Yiu Sung, Henry Lik‐Yuen Chan. Genetic polymorphisms of adiponectin and tumor necrosis factor‐alpha and nonalcoholic fatty liver disease in Chinese people. Journal of Gastroenterology and Hepatology 2008; 23(6): 914 doi: 10.1111/j.1440-1746.2008.05344.x
|
2 |
M. Nannipieri, F. Cecchetti, M. Anselmino, E. Mancini, G. Marchetti, A. Bonotti, S. Baldi, B. Solito, M. Giannetti, A. Pinchera, F. Santini, E. Ferrannini. Pattern of Expression of Adiponectin Receptors in Human Liver and its Relation to Nonalcoholic Steatohepatitis. Obesity Surgery 2009; 19(4): 467 doi: 10.1007/s11695-008-9701-x
|
3 |
Hamed Jafari-Vayghan, Ali Tarighat-Esfanjani, Mohammad Asghari Jafarabadi, Mehrangiz Ebrahimi-Mameghani, Sevda Saleh Ghadimi, Zahra Lalezadeh. Association Between Dietary Patterns and Serum Leptin-to-Adiponectin Ratio in Apparently Healthy Adults. Journal of the American College of Nutrition 2015; 34(1): 49 doi: 10.1080/07315724.2014.880389
|
4 |
Amedeo Lonardo, Cesare Carani, Nicola Carulli, Paola Loria. ‘Endocrine NAFLD’ a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis. Journal of Hepatology 2006; 44(6): 1196 doi: 10.1016/j.jhep.2006.03.005
|
5 |
Aimin Xu, Yu Wang, Karen S. L. Lam. Adipose Tissue and Adipokines in Health and Disease. Nutrition and Health 2007; : 47 doi: 10.1007/978-1-59745-370-7_4
|
6 |
Savvoula Savvidou, Prodromos Hytiroglou, Helen Orfanou-Koumerkeridou, Athanasia Panderis, Peggy Frantzoulis, John Goulis. Low Serum Adiponectin Levels Are Predictive of Advanced Hepatic Fibrosis in Patients With NAFLD. Journal of Clinical Gastroenterology 2009; 43(8): 765 doi: 10.1097/MCG.0b013e31819e9048
|
7 |
Olivia M. Tandrasasmita, Guntur Berlian, Raymond R. Tjandrawinata. Molecular mechanism of DLBS3733, a bioactive fraction of Lagerstroemia speciosa (L.) Pers., on ameliorating hepatic lipid accumulation in HepG2 cells. Biomedicine & Pharmacotherapy 2021; 141: 111937 doi: 10.1016/j.biopha.2021.111937
|
8 |
J.A. Paniagua, A. Gallego de la Sacristana, I. Romero, A. Vidal-Puig, J.M. Latre, E. Sanchez, P. Perez-Martinez, J. Lopez-Miranda, F. Perez-Jimenez. Monounsaturated Fat–Rich Diet Prevents Central Body Fat Distribution and Decreases Postprandial Adiponectin Expression Induced by a Carbohydrate-Rich Diet in Insulin-Resistant Subjects. Diabetes Care 2007; 30(7): 1717 doi: 10.2337/dc06-2220
|
9 |
January N. Baumgardner, Kartik Shankar, Leah Hennings, Thomas M. Badger, Martin J. J. Ronis. A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet. American Journal of Physiology-Gastrointestinal and Liver Physiology 2008; 294(1): G27 doi: 10.1152/ajpgi.00296.2007
|
10 |
Ying Liu, Ravi Retnakaran, Anthony Hanley, Rungsunn Tungtrongchitr, Collin Shaw, Gary Sweeney. Total and High Molecular Weight But Not Trimeric or Hexameric Forms of Adiponectin Correlate with Markers of the Metabolic Syndrome and Liver Injury in Thai Subjects. The Journal of Clinical Endocrinology & Metabolism 2007; 92(11): 4313 doi: 10.1210/jc.2007-0890
|
11 |
Yesim Ozturk, Ozlem Bekem Soylu. Fatty liver in childhood. World Journal of Hepatology 2014; 6(1): 33-40 doi: 10.4254/wjh.v6.i1.33
|
12 |
Savvoula Savvidou. Serum Adiponectin Concentration Decreases in Higher Stages of Hepatic Fibrosis Within the Entire Clinicopathologic Spectrum of NAFLD. Journal of Clinical Gastroenterology 2010; 44(3): 230 doi: 10.1097/MCG.0b013e3181c74e25
|
13 |
JinJin Yin, YanQin Luo, HouLiang Deng, ShuMin Qin, WaiJiao Tang, Lu Zeng, BenJie Zhou. Hugan Qingzhi medication ameliorates hepatic steatosis by activating AMPK and PPARα pathways in L02 cells and HepG2 cells. Journal of Ethnopharmacology 2014; 154(1): 229 doi: 10.1016/j.jep.2014.04.011
|
14 |
Hao Zheng, Shilin Li, Liang Ma, Ling Cheng, Chongyang Deng, Zhizhi Chen, Caifeng Xie, Mingli Xiang, Wei Jiang, Lijuan Chen. A novel agonist of PPAR-γ based on barbituric acid alleviates the development of non-alcoholic fatty liver disease by regulating adipocytokine expression and preventing insulin resistance. European Journal of Pharmacology 2011; 659(2-3): 244 doi: 10.1016/j.ejphar.2011.03.033
|